Lack Of Oversight By CMS To Ensure Private Medicare Drug Plans Have Anti-Fraud Programs In Place ‘Risks Significant Use Of Funds,’ According To GAO

CMS has not conducted audits to ensure that Medicare prescription drug plans have implemented programs to prevent fraud as required by law, a lack of oversight that “risks significant misuse of funds in this $39 billion program,” according to a Government Accountability Office report scheduled for release on Monday, the

More: continued here

Filed under: Medicare / Medicaid / Tricare on September 8th, 2008